Airdate: Friday, February 17, 2023 Season: 2 Episode: 2
Guests: Nataliia Beztsinna, Marten Hornsveld
In this special episode of Industry Insights, we spoke with Dr. Nataliia Beztsinna and Dr. Marten Hornsveld from Crown Bioscience. Nataliia and Marten talk about native and reconstituted TME assays, how they can help in the preparation for clinical trials, and what kinds of therapies in development would benefit the most from this kind of testing. To watch our recent webinar, Analyzing the Suppressive TME in in Vitro Based Assays, click here.
To read our recent blog article, “The Cancer-Immunity Cycle: Research Solutions for Preclinical Immuno-Oncology”, click here.
To watch the interview and read the full blog, click here.
Associated Webinar: Analyzing the Suppressive TME in in Vitro Based Assays
Similar Podcasts
#ExpertAnswers: Steven Loo-Yong-Kee on CRISPR-Edited T Cells
Steven Loo-Yong-Kee highlights Artisan Bio’s STAR-CRISPR system for optimized gene editing in cell therapy, with a focus on the genetic modification of T cells for cancer immunotherapy.
Talking Real Science with Ellie Siebeneck
Ellie Siebeneck is one of 10 winners of the inaugural Scientist.com STEM Research NIL Award. In this episode, she discusses her passion for learning, mentorship and where the road lies ahead for her academic journey.
#ExpertAnswers: Nataliia Beztsinna and Marten Hornsveld on Pre-Clinical Immuno-Oncology
Nataliia Beztsinna and Marten Hornsveld describe how the tumor microenvironment modulates clinical responses and how patient-derived ex vivo and engineered in vitro models can be used for pre-clinical immuno-oncology testing.
Related Content
Revolutionizing Immunotherapy Research with 3D, Multiplexed Cryo-fluorescence Tomography
Dr. Matt Silva showcases the power of cryo-fluorescence tomography (CFT) in advancing immunotherapy research.
Unlocking Spatial Insights: Accelerate Discoveries 70% Faster with SignalStar™ Multiplex IHC
Join us to learn how to accelerate spatial biology discoveries by 70% with optimized, ready-to-go panels using SignalStar™ Multiplex IHC.
Overcome the Multiple Challenges of Neutralizing Antibodies in Cancer Therapy Using Innovative Phage Display Technologies
In this webinar, Dr. Conor McCartin discusses how phage display can be used for human antibody development.